Ionis Pharmaceuticals Inc
(NAS:IONS)
$
35.91
-0.42 (-1.16%)
Market Cap: 5.74 Bil
Enterprise Value: 4.73 Bil
PE Ratio: 0
PB Ratio: 8.65
GF Score: 40/100 Ionis Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 05:00PM GMT
Release Date Price:
$33.03
(-3.28%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
We're about to get started with our next company presenter. Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analysts at BofA. And I'm pleased to be introducing our next company presenter, Ionis Pharmaceuticals and CFO, Beth Hougen. So Beth, thanks so much for joining us.
Elizabeth L. Hougen
Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Thanks for having us. It's great to be here and to be in person.
Questions & Answers
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Yes. Great. Well, we were talking about this before the start here. But maybe if you can just talk a little bit about Ionis and over the last few years, there's been a lot of changes in terms of the focus, what do you keep in-house? Will you partner? What do you guys want to be as you look to integrate with certain assets and bringing
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot